Autolus Inc.
Autolus Inc. is listed as the manufacturer on 1 FDA drug label records covering 1 distinct active ingredients predominantly cellular therapy products.
About Autolus Inc.
Autolus Inc. is named as the labeler on 1 FDA drug label records. Its catalogue spans 1 distinct active ingredients, led by OBECABTAGENE AUTOLEUCEL. Most of these labels are cellular therapy products. Labelling across this portfolio most often references: treatment adults, relapsed refractory, b-cell precursor, acute lymphoblastic, usage aucatzyl, directed genetically, modified autologous, cell immunotherapy. Use the table below to identify a specific product, then open it for full indications, dosage and warnings as filed with the FDA.
Active ingredients in this portfolio
| Active ingredient | Products |
|---|---|
| OBECABTAGENE AUTOLEUCEL | 1 |
FDA drug products from Autolus Inc.
| Brand name | Generic | Type | Route |
|---|---|---|---|
| AUCATZYL | OBECABTAGENE AUTOLEUCEL | CELLULAR THERAPY |
Frequently asked questions
How many FDA drug products does Autolus Inc. make?
1 FDA drug label records name Autolus Inc. as the manufacturer, covering 1 distinct active ingredients.
What active ingredients does Autolus Inc. produce?
The most frequent active ingredients in this portfolio are OBECABTAGENE AUTOLEUCEL.
Are Autolus Inc. products prescription or over-the-counter?
The largest share of this company’s labels are cellular therapy products; check each product page for its own marketing status.
Does this page list prices or where to buy?
No. This is a labelling reference built from FDA data. It does not sell, price or recommend any medicine.
Labelling data reproduced from FDA Structured Product Labelling for identification only. This site does not sell, price or recommend any medicine.